GZMB and neoplasm: Granzyme B (30 kDa) is one of the major effectors of cytotoxic T lymphocyte (CTL)-mediated cell death that is released into the extracellular space upon T-cell activation, where it penetrates target tumor cells via perforin-mediated entry [19].